News
Novo Nordisk’s Wegovy, the blockbuster weight loss drug, launched in India: How much will it cost?
Danish pharma giant Novo Nordisk on Tuesday launched its blockbuster weight loss drug Wegovy as a once-a-week injection in India. This adds to the option of weight loss drugs in India, with Eli Lilly’s injectable Mounjaro now also available in the country.
Novo Nordisk Has Ended Its Wegovy Deal With Hims & Hers: Here's What Investors Need to Know
Novo Nordisk (NYSE: NVO) and Hims & Hers Health (NYSE: HIMS) announced they were collaborating to allow Hims & Hers to sell the weight-loss drug Wegovy. Novo Nordisk revealed on Monday that it will no longer work with Hims & Hers,
Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the ...
WEIGHT loss jabs may also help ward off dementia, a new study suggests. Researchers found that semaglutide – the active ...
Novo Nordisk gearing up for pan-India launch of Wegovy, eyes Rs 8,600 crore in sales. (Image: Canva) Danish pharma giant Novo Nordisk is preparing for a major push in India with its blockbuster ...
Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...
The increasing demand for weight-loss jabs such as Mounjaro and Wegovy has helped sales at the firm behind Chemist4U almost ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback